Latest Insider Transactions at Viridian Therapeutics, Inc.\De (VRDN)
This section provides a real-time view of insider transactions for Viridian Therapeutics, Inc.\De (VRDN). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of Viridian Therapeutics, Inc.\DE to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of Viridian Therapeutics, Inc.\DE's insiders and make more informed investment decisions.
Insider Transaction List
Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
---|---|---|---|---|---|
Mar 02
2022
|
Jonathan Violin Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
11,106
-1.91%
|
$188,802
$17.36 P/Share
|
Mar 01
2022
|
Jonathan Violin Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
18,894
-3.14%
|
$321,198
$17.82 P/Share
|
Feb 03
2022
|
Jonathan Violin Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
909
-0.15%
|
$17,271
$19.16 P/Share
|
Feb 02
2022
|
Jonathan Violin Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
12,340
-2.01%
|
$222,120
$18.47 P/Share
|
Feb 01
2022
|
Jonathan Violin Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
16,751
-2.66%
|
$318,269
$19.55 P/Share
|
Dec 08
2021
|
Jonathan Violin Chief Executive Officer |
BUY
Conversion of derivative security
|
Direct |
627,564
+49.87%
|
-
|
Sep 23
2021
|
Frazier Life Sciences Public Fund, L.P. > 10% Shareholder |
BUY
Open market or private purchase
|
Direct |
200,000
+11.73%
|
$2,200,000
$11.0 P/Share
|
Sep 21
2021
|
Fairmount Funds Management LLC Director |
BUY
Open market or private purchase
|
Indirect |
909,000
+49.21%
|
$9,999,000
$11.0 P/Share
|
Nov 13
2020
|
Logos Global Master Fund LP > 10% Shareholder |
BUY
Open market or private purchase
|
Direct |
126,667
+18.72%
|
$1,773,338
$14.84 P/Share
|
Nov 09
2020
|
Logos Global Master Fund LP > 10% Shareholder |
BUY
Open market or private purchase
|
Direct |
350,000
+2.7%
|
$350,000
$1.13 P/Share
|
Oct 27
2020
|
Jonathan Violin Chief Executive Officer |
BUY
Other acquisition or disposition
|
Direct |
50,124
+50.0%
|
-
|
Oct 27
2020
|
Fairmount Funds Management LLC Director |
BUY
Other acquisition or disposition
|
Indirect |
526,393
+50.0%
|
-
|